Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
22.04. | BPH GLOBAL LTD: Consolidation/Split - BP8 | - | ASX | ||
22.04. | BPH GLOBAL LTD: EGM Letter of Access | - | ASX | ||
22.04. | BPH GLOBAL LTD: Notice of Extraordinary General Meeting/Proxy Form | - | ASX | ||
12.04. | BPH GLOBAL LTD: Initial Trading Results to be included in Appendix 4C Report | - | ASX | ||
11.04. | BPH GLOBAL LTD: Company Secretary Appointment & Change of Registered Office | - | ASX | ||
18.03. | BPH GLOBAL LTD: 120-Day Business Development Plan | - | ASX | ||
12.03. | BPH GLOBAL LTD: AI tech to expand seaweed R&D into battery industries | - | ASX | ||
27.02. | BPH GLOBAL LTD: Half Yearly Report and Accounts | - | ASX | ||
09.02. | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
09.02. | BPH GLOBAL LTD: Application for quotation of securities - BP8 | - | ASX | ||
04.02. | BPH GLOBAL LTD: Renewal of China Tobacco Agreements | - | ASX | ||
31.01. | BPH GLOBAL LTD: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
18.01. | BPH GLOBAL LTD: Change of Joint Company Secretary | 1 | ASX | ||
15.12.23 | BPH GLOBAL LTD: Change of Director's Interest Notice | 1 | ASX | ||
15.12.23 | BPH GLOBAL LTD: Change of Director's Interest Notice | 1 | ASX | ||
15.12.23 | BPH GLOBAL LTD: Change of Director's Interest Notice | 1 | ASX | ||
13.12.23 | BPH GLOBAL LTD: Sale of platform in East Johor Strait | - | ASX | ||
10.12.23 | BPH GLOBAL LTD: Completion of acquisition of Foshan Gedishi Biotechnology Co | - | ASX | ||
08.12.23 | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | 1 | ASX | ||
08.12.23 | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | 1 | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIRONA BIOCHEM | 0,045 | +3,45 % | Sirona Biochem Corp.: SIRONA BIOCHEM Corporate Update April 2024 | VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona" or the "Company") provides the following update: Dear shareholders... ► Artikel lesen | |
REPLENISH NUTRIENTS | 0,050 | +20,77 % | Replenish Nutrients Holding Corp: Replenish Nutrients partners with Dark Horse | ||
AYALA PHARMACEUTICALS | 0,485 | +1,04 % | Ayala Pharmaceuticals, Inc. - 10-K/A, Annual Report | ||
NEOVACS | 0,237 | -11,09 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.11.2023 | The following instruments on Boerse Frankfurt do have their last trading day on 16.11.2023.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.11.2023.ISIN NameAU000000SAU3 SOUTHERN... ► Artikel lesen | |
NANOSPHERE HEALTH SCIENCES | 0,012 | -36,84 % | The Morning After: 'Nanosphere' paint could reduce a plane's CO2 emissions | ||
GENETIC TECHNOLOGIES | 0,058 | -9,45 % | GENETIC TECHNOLOGIES LIMITED: Change in substantial holding | ||
TRIVARX | - | - | TRIVARX LTD: March 2024 Quarterly Activities Report and Appendix 4C | ||
EQUATORIAL RESOURCES | 0,079 | 0,00 % | EQUATORIAL RESOURCES LIMITED: March 2024 Quarterly Report | ||
RECCE PHARMACEUTICALS | 0,440 | +8,91 % | ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential | ||
PYC THERAPEUTICS | - | - | PYC THERAPEUTICS LIMITED: RP11 Drug Candidate Progressing to Mid-Stage Human Trials | ||
PATRYS | 0,004 | 0,00 % | Patrys releases positive data from deoxymabs study to treat ANCA vasculitis | ||
MORPHOSYS | 66,10 | -2,58 % | EQS-PVR: MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: MorphoSys AG
MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
22.04.2024 / 16:00 CET/CEST
Veröffentlichung... ► Artikel lesen | |
EVOTEC | 9,710 | +5,14 % | Aufholjagd BioTech 2024 - jetzt positionieren! Bayer, BioNTech, Defence Therapeutics, Evotec, BioNxt und Vidac Pharma im Fokus | BioTech-Investoren haben im Jahr 2024 bislang noch keine große Party feiern können. Das blieb eher den Spekulanten in den Sektoren Künstliche Intelligenz und Rüstung vorbehalten. Doch nun neigen sich... ► Artikel lesen | |
CULLINAN THERAPEUTICS | 25,300 | 0,00 % | Cullinan Therapeutics, Inc.: Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer | CAMBRIDGE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted therapies, today announced the appointment... ► Artikel lesen | |
RECURSION PHARMACEUTICALS | 8,120 | 0,00 % | Recursion Pharmaceuticals' Options Frenzy: What You Need to Know |